ARCHIMED completed the acquisition of Irrimax for c. $300m.

Synopsis

ARCHIMED, a global private equity healthcare specialist, completed the acquisition of Irrimax, a provider of solutions within high performance wound irrigation, for c. $300m. The market for high performance surgical and post-surgical wound irrigation is expected to grow significantly in the medium term.

Principals

target

IRRIMAX

bidder

Archimed

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Seller Team (3)

mark alvarez

CEO at IRRIMAX

Manager

target

Deal

£ 228 M

Total Value

chris rosselli

Partner at Eversheds Sutherland

Lawyer

target

Deals

£ 228 M

Total Value

wade stribling

Partner at Eversheds Sutherland

Lawyer

target

Deal

£ 228 M

Total Value

Bidder Team (1)

denis ribon

Chairman at ARCHIMED SAS

Investor

bidder

Deals

£ 707 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy